Hadassah, provider of 'Regulatory-Ready' pluripotent clinical-grade stem cell banks
The Hadassah hESC Research Center's aim is to be a supplier of clinical and research-grade human embryonic stem cell (hESC) lines. In 2012, we derived the first three entirely GMP-compliant and xeno-free, fully-characterised, feeder-dependent (human umbilical cord) hESC lines developed under cl...
Main Authors: | Shelly E Tannenbaum, Orna Singer, Yaniv Gil, Yael Berman-Zaken, Nili Ilouz, Hanita Khaner, Miriam Haimov, Benjamin E Reubinoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Stem Cell Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506119303009 |
Similar Items
-
Derivation of xeno-free and GMP-grade human embryonic stem cells--platforms for future clinical applications.
by: Shelly E Tannenbaum, et al.
Published: (2012-01-01) -
Canadian Hadassah-WIZO and the Establishment of the Women’s Agricultural School at Nahalal
by: Esther Carmel Hakim
Published: (2004-01-01) -
Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny.
by: Michal Gropp, et al.
Published: (2012-01-01) -
Israel's experience in the organization of the program of organ donation. Interview with transplantkoordinator Kirill Grozovskiy Hadassah University Hospital (Jerusalem, Israel)
by: V. L. Vinogradov
Published: (2016-02-01) -
Eric Mendelsohn: lugar, exigencias y expresión en el Centro Médico Universitario Hadassah en Monte Scopus (Jerusalén)
by: Marilda Azulay Tapiero
Published: (2017-07-01)